Production of 4,000 Final Lateral Flow Strips

The contract requires the manufacture of 4,000 final lateral flow strips for pre-clinical testing, strictly adhering to a validated design and specifications set by the Centers for Disease Control and Prevention. The work must be performed in compliance with all technical and quality requirements established by the CDC to ensure the strips are suitable for intended pre-clinical use. The project is classified as a subcontract under NAICS code 325414, which corresponds to pharmaceutical and biological product manufacturing, indicating the need for specialized expertise in diagnostic device production. The place of performance is designated as Atlanta, Georgia, with the final deliverables expected to meet CDC’s rigorous standards for accuracy, consistency, and functionality. The solicitation was posted on July 24, 2026, with a response deadline of July 29, 2026, at 7:00 PM Eastern Time, leaving a limited window for qualified vendors to submit proposals. The contracting agency is the CDC Office of Acquisition Services under the Department of Health and Human Services, underscoring the public health significance of the project. While no set-aside provisions or specific organization type requirements are noted, bidders must be prepared to demonstrate capacity, regulatory knowledge, and quality control processes capable of delivering precisely specified diagnostic strips under a tight timeframe. The opportunity is accessible through the SAM.gov platform, and full compliance with CDC guidelines is non-negotiable for contract award.